Dual receptor-targeted (DRT) radiation nanomedicine labeled with 177Lu is more potent for killing human breast cancer cells that co-express HER2 and EGFR than single receptor-targeted (SRT) radiation nanomedicines
Yook, Simmyung, Cai, Zhongli, Jeong, Jenny Jooyoung, Lu, Yijie, Winnik, Mitchell A., Pignol, Jean-Philippe, Reilly, Raymond MLangue:
english
Journal:
Molecular Pharmaceutics
DOI:
10.1021/acs.molpharmaceut.9b01259
Date:
February, 2020
Fichier:
PDF, 5.23 MB
english, 2020
File converter
Plus de résultats de recherche
More benefits 
